- Home
- VALN vs RENB Comparison
VALN vs RENB Comparison
Compare VALN & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- RENB
- Stock Information
- Founded
- VALN 2012
- RENB 2011
- Country
- VALN France
- RENB United States
- Employees
- VALN N/A
- RENB N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- VALN Health Care
- RENB Health Care
- Exchange
- VALN Nasdaq
- RENB Nasdaq
- Market Cap
- VALN 542.5M
- RENB 62.0M
- IPO Year
- VALN 2021
- RENB N/A
- Fundamental
- Price
- VALN N/A
- RENB $0.29
- Analyst Decision
- VALN Strong Buy
- RENB
- Analyst Count
- VALN 3
- RENB 0
- Target Price
- VALN $15.33
- RENB N/A
- AVG Volume (30 Days)
- VALN 11.8K
- RENB 4.2M
- Earning Date
- VALN 08-12-2025
- RENB 05-15-2025
- Dividend Yield
- VALN N/A
- RENB N/A
- EPS Growth
- VALN N/A
- RENB N/A
- EPS
- VALN N/A
- RENB N/A
- Revenue
- VALN $201,099,222.00
- RENB N/A
- Revenue This Year
- VALN $18.74
- RENB N/A
- Revenue Next Year
- VALN $29.26
- RENB N/A
- P/E Ratio
- VALN N/A
- RENB N/A
- Revenue Growth
- VALN 21.64
- RENB N/A
- 52 Week Low
- VALN $3.62
- RENB $0.27
- 52 Week High
- VALN $8.66
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- VALN 44.31
- RENB 40.92
- Support Level
- VALN $5.57
- RENB $0.33
- Resistance Level
- VALN $6.08
- RENB $0.37
- Average True Range (ATR)
- VALN 0.25
- RENB 0.04
- MACD
- VALN 0.02
- RENB -0.01
- Stochastic Oscillator
- VALN 44.93
- RENB 14.96
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.